Blue JT - Search Results

1

An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics.

Singh SK, Afonina N, Awwad M, Bechtold-Peters K, Blue JT, Chou D, Cromwell M, Krause HJ, Mahler HC, Meyer BK, Narhi L, Nesta DP, Spitznagel T. Singh SK, et al. Among authors: blue jt. J Pharm Sci. 2010 Aug;99(8):3302-21. doi: 10.1002/jps.22097. J Pharm Sci. 2010. PMID: 20310025 Review.

2

The use of flow cytometry for the detection of subvisible particles in therapeutic protein formulations.

Mach H, Bhambhani A, Meyer BK, Burek S, Davis H, Blue JT, Evans RK. Mach H, et al. Among authors: blue jt. J Pharm Sci. 2011 May;100(5):1671-8. doi: 10.1002/jps.22414. Epub 2010 Dec 13. J Pharm Sci. 2011. PMID: 21374606

3

Accelerating Vaccine Formulation Development Using Design of Experiment Stability Studies.

Ahl PL, Mensch C, Hu B, Pixley H, Zhang L, Dieter L, Russell R, Smith WJ, Przysiecki C, Kosinski M, Blue JT. Ahl PL, et al. Among authors: blue jt. J Pharm Sci. 2016 Oct;105(10):3046-3056. doi: 10.1016/j.xphs.2016.06.014. Epub 2016 Aug 11. J Pharm Sci. 2016. PMID: 27522919

4

High throughput formulation screening for global aggregation behaviors of three monoclonal antibodies.

Li Y, Mach H, Blue JT. Li Y, et al. Among authors: blue jt. J Pharm Sci. 2011 Jun;100(6):2120-35. doi: 10.1002/jps.22450. Epub 2011 Jan 6. J Pharm Sci. 2011. PMID: 21491438

5

Characterization of Propylene Glycol-Mitigated Freeze/Thaw Agglomeration of a Frozen Liquid nOMV Vaccine Formulation by Static Light Scattering and Micro-Flow Imaging.

Mensch CD, Davis HB, Blue JT. Mensch CD, et al. Among authors: blue jt. PDA J Pharm Sci Technol. 2015 Jul-Aug;69(4):477-98. doi: 10.5731/pdajpst.2015.01057. PDA J Pharm Sci Technol. 2015. PMID: 26242785

6

Enabling Lyophilized Pneumococcal Conjugate Vaccines Through Formulation Design and Excipient Selection Suitable for A Multivalent Adjuvanted Vaccine.

Mensch C, Chintala R, Nawrocki D, Blue JT, Bhambhani A. Mensch C, et al. Among authors: blue jt. J Pharm Sci. 2021 Jan;110(1):97-107. doi: 10.1016/j.xphs.2020.10.038. Epub 2020 Oct 23. J Pharm Sci. 2021. PMID: 33164785 Free article.

7

Evaluation of Microwave Vacuum Drying as an Alternative to Freeze-Drying of Biologics and Vaccines: the Power of Simple Modeling to Identify a Mechanism for Faster Drying Times Achieved with Microwave.

Bhambhani A, Stanbro J, Roth D, Sullivan E, Jones M, Evans R, Blue J. Bhambhani A, et al. AAPS PharmSciTech. 2021 Jan 19;22(1):52. doi: 10.1208/s12249-020-01912-9. AAPS PharmSciTech. 2021. PMID: 33469785 Free PMC article.

8

Detecting and preventing reversion to toxicity for a formaldehyde-treated C. difficile toxin B mutant.

Wang B, Wang S, Rustandi RR, Wang F, Mensch CD, Hong L, Kristopeit A, Secore S, Dornadula G, Kanavage A, Heinrichs JH, Mach H, Blue JT, Thiriot DS. Wang B, et al. Among authors: blue jt. Vaccine. 2015 Jan 1;33(1):252-9. doi: 10.1016/j.vaccine.2014.06.032. Epub 2014 Jun 18. Vaccine. 2015. PMID: 24951860 Free article.

9

Examination of the effect of agitation on the potency of the Ebola Zaire vaccine rVSVΔG-ZEBOV-GP.

Davis H, Dow T, Isopi L, Blue JT. Davis H, et al. Among authors: blue jt. Vaccine. 2020 Mar 10;38(12):2643-2645. doi: 10.1016/j.vaccine.2020.02.002. Epub 2020 Feb 18. Vaccine. 2020. PMID: 32081445

10

High Throughput Differential Scanning Fluorimetry (DSF) Formulation Screening with Complementary Dyes to Assess Protein Unfolding and Aggregation in Presence of Surfactants.

McClure SM, Ahl PL, Blue JT. McClure SM, et al. Among authors: blue jt. Pharm Res. 2018 Mar 5;35(4):81. doi: 10.1007/s11095-018-2361-1. Pharm Res. 2018. PMID: 29508082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters